Adverse Outcome Pathway-Informed Integrated Testing to Identify Chemicals Causing Genotoxicity Through Oxidative DNA Damage: Case Study on 4-Nitroquinoline 1-Oxide
- PMID: 40341686
- PMCID: PMC12087725
- DOI: 10.1002/em.70011
Adverse Outcome Pathway-Informed Integrated Testing to Identify Chemicals Causing Genotoxicity Through Oxidative DNA Damage: Case Study on 4-Nitroquinoline 1-Oxide
Abstract
Adverse outcome pathways (AOPs) provide a framework to organize and weigh evidence linking molecular interactions of toxicants in cells to adverse outcomes relevant to risk assessment or regulatory decision-making. Applying this framework facilitates the interpretation of data produced using new test methods. We used an existing AOP (AOP #296) that describes how oxidative DNA damage leads to mutations and chromosomal aberrations to develop an integrated testing strategy to evaluate whether a chemical operates through this pathway. We exposed human TK6 cells to increasing concentrations of 4-nitroquinoline 1-oxide (4NQO), a tobacco mimetic that causes oxidative DNA damage, in a time-series design. We measured oxidative DNA damage and strand breaks using the high-throughput CometChip assay with and without formamidopyrimidine DNA glycosylase (Fpg), alongside analyses of micronucleus (MN) frequency by flow cytometry, and mutations by error-corrected sequencing (duplex sequencing-DS). Our analysis shows how these methods can be combined to quantify 4NQO-induced, concentration- and time-dependent increases in: (a) oxidative DNA damage (occurred early and at low concentrations); (b) strand breaks (remained elevated to 6 h post-exposure); (c) MN frequency (at 24 h); (d) mutation frequency (at 48 h); and (e) C > A transversions consistent with expected substitutions induced by oxidative DNA lesions. The time series shows the repair of oxidative DNA damage with persistent strand breaks remaining at 6 h. Overall, we provide an example of an AOP-informed testing strategy and contribute to the quantitative understanding of AOP #296. We also demonstrate the value of DS as an effective approach for mutagenicity assessment.
Keywords: adverse outcome pathway; duplex sequencing; error‐corrected sequencing; genetic toxicology; in vitro toxicology; new approach methodologies.
© 2025 His Majesty the King in Right of Canada, Scitovation and The Author(s). Environmental and Molecular Mutagenesis published by Wiley Periodicals LLC on behalf of Environmental Mutagenesis and Genomics Society. Reproduced with the permission of the Minister of Health Canada.
Figures






References
-
- Abraham, S. K. , Schupp N., Schmid U., and Stopper H.. 2007. “Antigenotoxic Effects of the Phytoestrogen Pelargonidin Chloride and the Polyphenol Chlorogenic Acid.” Molecular Nutrition & Food Research 51: 880–887. - PubMed
-
- Ankley, G. T. , Bennett R. S., Erickson R. J., et al. 2010. “Adverse Outcome Pathways: A Conceptual Framework to Support Ecotoxicology Research and Risk Assessment.” Environmental Toxicology and Chemistry 29: 730–741. - PubMed
-
- Arima, Y. , Nishigori C., Takeuchi T., et al. 2006. “4‐Nitroquinoline 1‐Oxide Forms 8‐Hydroxydeoxyguanosine in Human Fibroblasts Through Reactive Oxygen Species.” Toxicological Sciences 91: 382–392. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources